Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000309150 | SCV000355612 | uncertain significance | Peroxisome biogenesis disorder 6A (Zellweger) | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Eurofins Ntd Llc |
RCV000676044 | SCV000705535 | uncertain significance | not provided | 2018-06-29 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000676044 | SCV000801778 | uncertain significance | not provided | 2023-02-09 | criteria provided, single submitter | clinical testing | BP4 |
Labcorp Genetics |
RCV001037362 | SCV001200772 | uncertain significance | Peroxisome biogenesis disorder, complementation group 7 | 2022-11-01 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 140 of the PEX10 protein (p.Gly140Arg). This variant is present in population databases (rs76530653, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with PEX10-related conditions. ClinVar contains an entry for this variant (Variation ID: 296280). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002480074 | SCV002793936 | uncertain significance | Peroxisome biogenesis disorder 6A (Zellweger); Peroxisome biogenesis disorder 6B | 2021-12-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002520466 | SCV003671081 | likely benign | Inborn genetic diseases | 2021-10-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV000676044 | SCV005186759 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001272167 | SCV001453862 | uncertain significance | Zellweger spectrum disorders | 2019-11-11 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003957547 | SCV004772485 | likely benign | PEX10-related disorder | 2022-03-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |